SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-05-009893
Filing Date
2005-11-09
Accepted
2005-11-09 12:39:30
Documents
10
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. 10-Q a5008244.htm 10-Q 544507
2 EXHIBIT 10.1 a5008244ex10_1.htm EX-10.1 192403
3 EXHIBIT 10.2 a5008244ex102.htm EX-10.2 16288
4 EXHIBIT 10.3 a5008244ex103.htm EX-10.3 221799
5 EXHIBIT 10.4 a5008244ex104.htm EX-10.4 22512
6 EXHIBIT 10.5 a5008244ex105.htm EX-10.5 13499
7 EXHIBIT 10.6 a5008244ex106.htm EX-10.6 9086
8 EXHIBIT 31.1 a5008244ex311.htm EX-31.1 15180
9 EXHIBIT 31.2 a5008244ex312.htm EX-31.2 13165
10 EXHIBIT 32.1 a5008244ex321.htm EX-32.1 6326
  Complete submission text file 0001157523-05-009893.txt   1056163
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 051188770
SIC: 2836 Biological Products, (No Diagnostic Substances)